Lisinopril Overdose and Accidental Excess Dose: Recognition, Risks, and Emergency Management

How Lisinopril Works and Why Overdose Causes Hypotension

Lisinopril is a lysine analog of enalaprilat that inhibits angiotensin-converting enzyme (ACE), blocking the conversion of angiotensin I to angiotensin II. This suppresses aldosterone secretion, reduces peripheral vascular resistance, and lowers blood pressure. The drug requires no hepatic activation, unlike enalapril or benazepril, because it is already in its active diacid form 1.

In overdose, this mechanism becomes exaggerated. The near-complete suppression of circulating angiotensin II removes a primary driver of arteriolar tone and aldosterone-mediated sodium retention. Blood pressure drops, sometimes precipitously. The renin-angiotensin-aldosterone system (RAAS) cannot compensate because the enzyme itself is saturated with inhibitor.

Lisinopril reaches peak plasma concentration at approximately 7 hours at therapeutic doses, but absorption kinetics can shift in overdose 2. The drug has no protein binding and a half-life of roughly 12 hours. Because it is renally cleared without hepatic metabolism, patients with baseline kidney disease face prolonged exposure after an excess dose.

One practical point: lisinopril's long duration of action (24 hours at therapeutic doses) means hypotensive effects from overdose can persist well beyond the typical 4-to-6-hour emergency department observation window used for many oral medications 3.

Defining Overdose: Therapeutic Range Versus Toxic Thresholds

The FDA-approved dose ceiling is 80 mg daily for hypertension and 40 mg daily for heart failure 2. A single accidental double dose (for example, 20 mg instead of 10 mg) in a patient with normal renal function and no concurrent potassium-sparing diuretics is unlikely to produce dangerous toxicity. Monitor at home and skip the next dose if symptomatic dizziness occurs.

Intentional ingestions change the equation entirely. Case reports document survival after single ingestions of 200 to 400 mg, though severe hypotension requiring vasopressor support was the rule in these cases 4. The American Association of Poison Control Centers (AAPCC) Annual Report for 2022 recorded over 12,000 single-substance ACE inhibitor exposures, with lisinopril as the most frequently implicated agent, and documented two fatalities attributed to ACE inhibitor overdose that year 5.

No published LD50 exists for lisinopril in humans. That gap matters. It means clinicians rely on case-series data and clinical judgment rather than a clean toxicity threshold.

The ALLHAT trial (N=33,357), while designed to compare antihypertensive classes rather than study overdose, confirmed lisinopril's hemodynamic profile: participants on lisinopril 10 to 40 mg daily showed mean systolic BP reductions of 11 mmHg, providing a reference frame for the magnitude of blood pressure change at therapeutic doses 3.

Recognizing Overdose Symptoms

Hypotension dominates the clinical picture. Patients may report lightheadedness, visual dimming, or syncope. Reflex tachycardia often follows but may be blunted in patients on concurrent beta-blockers.

Beyond blood pressure, watch for these findings:

• Acute kidney injury. Reduced renal perfusion from hypotension, compounded by loss of angiotensin II-mediated efferent arteriolar tone, can raise serum creatinine within hours 6.
• Hyperkalemia. Aldosterone suppression impairs renal potassium excretion. In patients with CKD stage 3 or higher, potassium levels above 6.5 mEq/L have been reported following ACE inhibitor excess 7.
• Bradycardia. Vagally mediated slowing can occur in severe hypotension, though sustained bradycardia is uncommon with pure ACE inhibitor toxicity.
• Angioedema. Rare in overdose specifically, but ACE inhibitor-associated angioedema occurs in 0.1% to 0.7% of patients at therapeutic doses 8. The incidence after overdose is not well characterized.

Symptoms typically begin 1 to 4 hours after ingestion. A completely asymptomatic patient at 6 hours post-ingestion of a known amount is reassuring but does not eliminate risk if the ingested dose was very large.

Emergency Department Management

The American College of Medical Toxicology recommends a supportive care approach for ACE inhibitor overdose, given the absence of a specific antidote 9.

Initial stabilization. Place the patient supine with legs elevated. Obtain IV access. Run a 500 mL to 1 L bolus of 0.9% normal saline. Recheck blood pressure every 5 minutes during the first 30 minutes. Most mild-to-moderate overdoses respond to fluid resuscitation alone.

Vasopressors. If systolic BP remains below 90 mmHg despite 2 L of crystalloid, start norepinephrine at 0.1 to 0.3 mcg/kg/min. Norepinephrine is preferred over phenylephrine because it provides both alpha-1 and beta-1 stimulation, addressing both vascular tone and cardiac output 10.

Activated charcoal. Consider 50 g of activated charcoal if the patient presents within 1 hour of ingestion, is protecting their airway, and has no contraindications. Beyond 1 hour, benefit is unlikely given lisinopril's absorption profile.

Hemodialysis. Lisinopril is dialyzable because it has no protein binding and a molecular weight of 405 Da 2. In practice, dialysis is reserved for patients with concurrent refractory hyperkalemia or acute kidney injury rather than for drug removal alone.

Laboratory monitoring. Draw a basic metabolic panel at presentation and repeat at 4 hours. Key values: serum potassium, creatinine, and bicarbonate. An ECG should be obtained if potassium exceeds 5.5 mEq/L.

Dr. Robert Hoffman, Director of the Division of Medical Toxicology at NYU Langone, has noted: "ACE inhibitor overdoses are generally forgiving compared to other cardiovascular drug classes. The real danger is not the ACE inhibitor itself but the co-ingestants, particularly beta-blockers or calcium channel blockers, which compound the hypotension through independent mechanisms" 9.

The Accidental Double Dose: A Common Scenario

Taking two lisinopril tablets instead of one is the most frequent overdose scenario encountered in primary care. National Poison Data System records indicate that unintentional therapeutic errors account for roughly 60% of all ACE inhibitor exposure calls 5.

For a patient on 10 mg daily who takes 20 mg by mistake: the ingested dose remains within the FDA-approved range. No emergency evaluation is needed. Skip the next day's dose and resume normal dosing the following day.

For a patient on 40 mg daily who takes 80 mg: this reaches the maximum labeled dose. Monitor blood pressure at home if a cuff is available. Seek medical attention if systolic BP drops below 90 mmHg, dizziness prevents standing, or urine output drops noticeably over 8 hours.

The Endocrine Society's 2020 clinical practice guidelines on hypertension management reinforce that "single-episode dose duplication of an ACE inhibitor in patients with preserved renal function carries a low probability of clinically significant adverse events" 11.

Pill organizer use reduces accidental double-dosing. A 2018 systematic review in the Annals of Internal Medicine found that multi-compartment medication aids decreased self-reported dosing errors by 34% (pooled OR 0.66 to 95% CI 0.51 to 0.87) 12.

Co-Ingestant Risks and Polypharmacy Considerations

Pure lisinopril overdose is rarely lethal. Fatalities linked to ACE inhibitor overdose almost always involve co-ingestants. The AAPCC 2022 report noted that both ACE inhibitor-associated deaths involved multi-drug ingestions 5.

Combinations that amplify risk include:

• Beta-blockers. Additive hypotension plus loss of compensatory tachycardia. Atenolol and metoprolol are the most commonly co-prescribed agents with lisinopril.
• Potassium supplements or potassium-sparing diuretics. Spironolactone plus lisinopril overdose can produce life-threatening hyperkalemia (potassium >7.0 mEq/L) rapidly 7.
• NSAIDs. Ibuprofen and naproxen further reduce glomerular filtration by blocking prostaglandin-mediated afferent arteriolar dilation, compounding the renal insult from ACE inhibitor excess 6.
• Amlodipine or other calcium channel blockers. These are frequently co-prescribed (the lisinopril-amlodipine combination is a guideline-recommended pairing per JNC 8), but in overdose, the combination produces refractory hypotension that may require high-dose insulin-euglycemic therapy 13.

Any patient presenting after intentional polydrug ingestion including lisinopril should be triaged as a high-acuity case regardless of initial blood pressure readings.

Pediatric Overdose Considerations

Accidental lisinopril ingestion in children younger than 6 years represents a distinct clinical scenario. A single tablet of lisinopril 5 mg in a 10 kg toddler delivers 0.5 mg/kg, which exceeds the upper pediatric dosing range of 0.1 to 0.6 mg/kg/day used in clinical trials 14.

The UpToDate pediatric toxicology review recommends emergency department evaluation for any child under 6 who ingests more than one lisinopril tablet, regardless of strength 14. Blood pressure monitoring should continue for at least 6 hours. Asymptomatic children may be discharged after this observation period if blood pressure, heart rate, and potassium remain within normal pediatric ranges.

Dr. Michael Burns, Associate Medical Director of the Regional Center for Poison Control at Boston Children's Hospital, has stated: "One pill can cause symptoms in a toddler. We use the 'one pill can kill' framework for several drug classes, and while ACE inhibitors are not in that group, they can still produce clinically significant hypotension in small children from a single adult-strength tablet" 9.

Long-Term Consequences After Overdose

Recovery from lisinopril overdose is typically complete within 24 to 48 hours once blood pressure normalizes. Persistent renal injury is uncommon if hypotension is corrected promptly.

Two exceptions merit attention. Patients who experienced prolonged hypotension (systolic BP <70 mmHg for more than 30 minutes) may develop acute tubular necrosis (ATN), requiring days to weeks for renal recovery 6. Patients with pre-existing bilateral renal artery stenosis face amplified risk of ischemic nephropathy because ACE inhibition removes the angiotensin II-dependent efferent tone that maintains glomerular filtration pressure in these kidneys 15.

After any overdose event, the prescribing clinician should reassess the risk-benefit of continuing lisinopril. For accidental overdoses, medication reconciliation and a pillbox system address the proximate cause. For intentional overdoses, psychiatric evaluation takes priority, and the clinician should consider switching to a shorter-acting antihypertensive with a smaller pill count to reduce future lethality in the home medication supply.

When to Call Poison Control Versus 911

Call Poison Control (1-800-222-1222) first if the patient is awake, alert, breathing normally, and the ingestion was unintentional. Poison Control toxicologists can risk-stratify the exposure by phone and advise whether home monitoring is sufficient.

Call 911 if any of these are present: loss of consciousness, systolic BP below 80 mmHg, chest pain, difficulty breathing, or suspected intentional self-harm. Do not induce vomiting. Do not give fluids by mouth to an obtunded patient.

Patients with renal impairment (eGFR <45 mL/min/1.73 m²) who take more than twice their prescribed dose should be evaluated in person even if asymptomatic, because lisinopril's clearance is proportionally reduced and peak drug effect may be delayed 2.

The threshold for emergency evaluation: any ingestion exceeding 80 mg total, any symptomatic patient, any pediatric exposure beyond a single low-dose tablet, or any intentional overdose regardless of amount.